Along this line, we have recently showed that FGFR2-IgIIIb and EGFR engage in reciprocal regulation of each other’s signaling and trafficking in breast cancer cells [275], confirming that FGFR trafficking regulation may become a target for therapeutic intervention. The gene discussed is FGFR2; the disease is breast carcinoma.